Name: 16th International Conference on Cancer Stem Cell & Oncology Research
Start: 2025-04-21
End: 2025-04-22
Location: Amsterdam, Netherlands

Browse all Webinars & Conferences

By Subject By Country 2025 2024 2023 2022 2021 2020 2019 2018 About Us Contact Us Welcome Message Award Nominations Advertising Opportunities Experts Outlook Workshops & symposia Poster Awards YRF Awards Most Recent Conferences Previous Conferences

Canada Brazil Australia China Hong Kong India Japan New Zealand Philippines Singapore Austria Belgium Czech Republic Denmark Finland France Germany Greece Hungary Ireland Luxembourg Netherlands Norway Poland Portugal Romania Russia Slovenia South Africa Spain Sweden Switzerland UK

Oncology & Cancer Conferences

Cancer Conferences | Cancer Research Conferences | Oncology Conferences | Cancer Science Conferences | Cancer Therapy Conferences | World Cancer Congress | Breast Cancer Conferences | Blood Cancer Conferences | Cancer Stem Cell Conferences | Bone Marrow Conferences | European Cancer Conferences

Oncology means an area of medical science which deals with tumours and cancers. The word onco means mass, bulk, or tumor while logy means study. A medical practitioner who treats oncology is known as an oncologist. Usually, an oncologist deals with care and treatment once a person is diagnosed with cancer. Cancer is an abnormal cell growth with the possibility to spread or invade to other parts of the body as well. Not all tumors are cancerous which benign tumors do not extend to other body parts. Cancer also called as a malignant neoplasm or malignant tumor.

Conference Series organizes numerous Cancer conferences on different types of cancers such as breast cancer, leukemia, oral cancer, skin cancer, lung cancer, colon cancer, rectal cancer, prostate cancer, cervical cancer, melanoma and carcinoma. Symptoms may vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery. Now a day’s vaccines were also available for specific cancer.

Numerous Oncology & Cancer Conferences are organized by Conference Series. 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business through different parts of the globe such as USA, Canada, Europe, UK, Middle East, UAE and other Asia Pacific region. Young Researcher Forum, Best poster awards, E-poster, Live Streaming, B2B meetings, exhibition and sponsorship opportunities are other significant features of these Cancer Meetings.

Oncology conferences and Cancer meetings provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings. B2B Meetings are a quick and easy way to meet potential cooperation partners.

About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumour in men, has an increasingly favourable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

The global cancer/tumor profiling market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018. Global oncology spending hit $91 billion for 2013 and it's growing at a 5% clip annually, which will cross $100 billion in 2015. The key players in the cancer/tumor profiling market are Boreal Genomics Inc. (U.S.), Caris Life Sciences (U.S.), Genomic Health Inc. (U.S.), Illumina Inc. (U.S.), Life Technologies Corporation (U.S.), NeoGenomics Laboratories (U.S.), Oxford Gene Technology Ltd. (U.K.), Precision Therapeutics Inc. (U.S.), bioTheranostics (U.S.), Proteome Sciences PLC (U.K.), Agendia (The Netherlands), Nanostring Technologies (U.S.), Rational Therapeutics (U.S.), Oncopath Laboratories (U.S.), and RiboMed BiotechnologiesInc. (U.S.). Global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. According to the market the global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020.

Target audiences at Oncology and Cancer conferences

Cancer research Students, Scientists
Cancer Researchers
Cancer research Faculty
Medical Colleges
Cancer Associations and Societies
Oncologists
Radiologists
Chemotherapists
Pathologists
Physicians
Business Entrepreneurs
Medical Devices Manufacturing Companies
Pharmaceutical Companies
Diagnostics Companies

Oncology & Cancer Associations throughout the world:

Associated Companies:

Abbott Laboratories
AbbVie
ACS Biomarker B.V.
Actavis USA
Affymetrix, Inc
Alizé Pharma
Amgen USA
Ariad Pharmaceuticals, Inc.
AstraZeneca
Benco Dental
Biogen Idec USA
BioHorizons
BioM AG Munich
Biomarker Pharmaceuticals, Inc.
Boehringer Ingelheim
Bristol-Myers Squibb USA
Carestream Dental
Celgene USA
Celldex Therapeutics
Centrix Dental
Clovis Oncology
Delta Dental
Dendreon
DenMat
DentistryIQ
DENTRIX Ascend
DENTSPLY Implants
Eli Lilly & Co USA
Gilead Sciences
GlaxoSmithKline
Glidewell Laboratories
Henry Schein
Integrated Dental Systems
Johnson & Johnson
Johnson & Johnson US
Kerr Dental Company | Kerr Dental
Lupin Ltd.
Marotta Dental Studio
Medivation
Merck
Merck & Co.
Merck USA
Novartis
Omnia LLC
Oncogenex
OralCDx
OralID
Panaeca Biotech Ltd.
PATTERSON Dental
Pfizer
Pfizer USA
Pharmacyclics
Pharmascience Inc.
Piramal Healthcare
PLANMECA -Digital Perfection
Prostagene
Radient Pharmaceuticals
Ranbaxy
RaySearch Laboratories
Roche
Roche Diagnostics Corporation
Sanofi
Sanofi FRA
Spectrum Pharmaceuticals, Inc. - Acute lymphoblastic leukemia
Sun pharma
Takeda
Takeda
US Biomarkers
Zimmer Dental

Top Universities and Research institutes:

Here Conferences and Programs are announced to keep update our clients and to bookmark their dates. However, Registrations are not allowed before 12 months of the conference.

Oncology Cancer Meetings

Browse all Webinars & Conferences